[HTML][HTML] Post-finasteride syndrome: a surmountable challenge for clinicians

AM Traish - Fertility and sterility, 2020 - Elsevier
Post-finasteride syndrome (PFS) is a constellation of serious adverse side effects manifested
in clinical symptoms that develop and persist in patients during and/or after discontinuing …

Adverse effects of 5α-reductase inhibitors: what do we know, don't know, and need to know?

AM Traish, RC Melcangi, M Bortolato… - Reviews in Endocrine …, 2015 - Springer
Steroids are important physiological orchestrators of endocrine as well as peripheral and
central nervous system functions. One of the key processes for regulation of these molecules …

Depressive symptoms and suicidal thoughts among former users of finasteride with persistent sexual side effects

MS Irwig - The Journal of clinical psychiatry, 2012 - legacy.psychiatrist.com
Objective: Finasteride, a commonly prescribed medication for male pattern hair loss, has
recently been associated with persistent sexual side effects. In addition, depression has …

Neuroactive steroid levels and psychiatric and andrological features in post-finasteride patients

RC Melcangi, D Santi, R Spezzano, M Grimoldi… - The Journal of steroid …, 2017 - Elsevier
Recent reports show that, in patients treated with finasteride for male pattern hair loss,
persistent side effects including sexual side effects, depression, anxiety and cognitive …

Effect of 5α-reductase inhibitors on sexual function: a meta-analysis and systematic review of randomized controlled trials

L Liu, S Zhao, F Li, E Li, R Kang, L Luo… - The journal of sexual …, 2016 - academic.oup.com
ABSTRACT Introduction 5α-Reductase inhibitors (5ARIs) are widely used for the treatment
of benign prostatic hyperplasia (BPH) and androgenetic alopecia (AGA). Aim To review all …

[PDF][PDF] The dark side of 5α-reductase inhibitors' therapy: sexual dysfunction, high Gleason grade prostate cancer and depression

AM Traish, A Mulgaonkar… - Korean journal of …, 2014 - synapse.koreamed.org
With aging, abnormal benign growth of the prostate results in benign prostate hyperplasia
(BPH) with concomitant lower urinary tract symptoms (LUTS). Because the prostate is an …

[HTML][HTML] Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride

T Kiguradze, WH Temps, PR Yarnold, J Cashy… - PeerJ, 2017 - peerj.com
Objective Our chief objective was to assess whether longer duration of 5α-RI exposure
increases risk of PED, independent of age and other known risk factors. Men with shorter 5α …

Negative impact of testosterone deficiency and 5α-reductase inhibitors therapy on metabolic and sexual function in men

AM Traish - Sex and Gender Factors Affecting Metabolic …, 2017 - Springer
Androgens are steroid hormones with pleotropic and diverse biochemical and physiological
functions, and androgen deficiency exerts a negative impact on human health. Testosterone …

Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction

A Traish, KS Haider, G Doros, A Haider - … molecular biology and …, 2017 - degruyter.com
Background Dutasteride has been successfully used in treatment of lower urinary tract
symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). However, dutasteride …

[HTML][HTML] Health risks associated with long-term finasteride and dutasteride use: it's time to sound the alarm

AM Traish - The World Journal of Men's Health, 2020 - ncbi.nlm.nih.gov
Abstract 5α-dihydrotestosterone (5α-DHT) is the most potent natural androgen. 5α-DHT
elicits a multitude of physiological actions, in a host of tissues, including prostate, seminal …